These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1279 related articles for article (PubMed ID: 27208430)

  • 1. Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection.
    Ghosh S; Nandi M; Pal S; Mukhopadhyay D; Chakraborty BC; Khatun M; Bhowmick D; Mondal RK; Das S; Das K; Ghosh R; Banerjee S; Santra A; Chatterjee M; Chowdhury A; Datta S
    Clin Microbiol Infect; 2016 Aug; 22(8):733.e9-733.e19. PubMed ID: 27208430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural Killer Group 2A Expressed on Both Peripheral CD3
    Yi RT; Niu YH; Liu HL; Zhang TY; Yang YC; Zhang Y; Yin DL; Chen TY; Zhao YR
    J Interferon Cytokine Res; 2016 Dec; 36(12):689-697. PubMed ID: 27828717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon-γ or interleukin-10 are expanded in asymptomatic, E antigen-negative patients with persistent hepatitis B virus infection.
    Conroy MJ; Mac Nicholas R; Grealy R; Taylor M; Otegbayo JA; O'Dea S; Mulcahy F; Ryan T; Norris S; Doherty DG
    J Viral Hepat; 2015 Mar; 22(3):335-45. PubMed ID: 25186004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated natural killer cells accelerate liver damage in patients with chronic hepatitis B virus infection.
    Zheng Q; Zhu YY; Chen J; Ye YB; Li JY; Liu YR; Hu ML; Zheng YC; Jiang JJ
    Clin Exp Immunol; 2015 Jun; 180(3):499-508. PubMed ID: 25639451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly activated TRAIL
    Jiang Y; Qin S; Wei X; Liu X; Guan J; Zhu H; Chang G; Chen Y; Lu H; Qian J; Wang Z; Shen M; Lin X
    Immunol Lett; 2021 Apr; 232():9-19. PubMed ID: 33515618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD56
    Shi A; Zhang X; Xiao F; Zhu L; Yan W; Han M; Luo X; Chen T; Ning Q
    J Viral Hepat; 2018 Nov; 25(11):1352-1362. PubMed ID: 29888839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural Killer p46 Controls Hepatitis B Virus Replication and Modulates Liver Inflammation.
    Li W; Jiang Y; Wang X; Jin J; Qi Y; Chi X; Zhang H; Feng X; Niu J
    PLoS One; 2015; 10(8):e0135874. PubMed ID: 26291078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural Killer Cell Characteristics in Patients With Chronic Hepatitis B Virus (HBV) Infection Are Associated With HBV Surface Antigen Clearance After Combination Treatment With Pegylated Interferon Alfa-2a and Adefovir.
    Stelma F; de Niet A; Tempelmans Plat-Sinnige MJ; Jansen L; Takkenberg RB; Reesink HW; Kootstra NA; van Leeuwen EM
    J Infect Dis; 2015 Oct; 212(7):1042-51. PubMed ID: 25791117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery of circulating CD56
    Liu N; Liu B; Zhang L; Li H; Chen Z; Luo A; Chen M; Peng M; Yin W; Ren H; Hu P
    Int Immunopharmacol; 2018 Sep; 62():59-66. PubMed ID: 29990695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B.
    Wijaya RS; Read SA; Schibeci S; Eslam M; Azardaryany MK; El-Khobar K; van der Poorten D; Lin R; Yuen L; Lam V; George J; Douglas MW; Ahlenstiel G
    J Hepatol; 2019 Aug; 71(2):252-264. PubMed ID: 30905683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8
    Nandi M; Pal S; Ghosh S; Chakraborty BC; Dey D; Baidya A; Shil A; Chattopadhyaya S; Banerjee S; Santra A; Chowdhury A; Datta S
    Clin Sci (Lond); 2019 Sep; 133(17):1917-1934. PubMed ID: 31477625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with telbivudine positively regulates antiviral immune profiles in Chinese patients with chronic hepatitis B.
    Ma L; Cai YJ; Yu L; Feng JY; Wang J; Li C; Niu JQ; Jiang YF
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1304-11. PubMed ID: 23274669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrahepatic natural killer cell activation, but not function, is associated with HBsAg levels in patients with HBeAg-negative chronic hepatitis B.
    Tjwa ET; Zoutendijk R; van Oord GW; Biesta PJ; Verheij J; Janssen HL; Woltman AM; Boonstra A
    Liver Int; 2014 Mar; 34(3):396-404. PubMed ID: 23890390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional restoration of CD56
    Chen T; Zhu L; Shi A; Ding L; Zhang X; Tan Z; Guo W; Yan W; Han M; Jia J; Luo X; Schuppan D; Ning Q
    Hepatol Int; 2017 Sep; 11(5):419-428. PubMed ID: 28639033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response pattern varies with the natural history of chronic hepatitis B.
    Wang WT; Zhao XQ; Li GP; Chen YZ; Wang L; Han MF; Li WN; Chen T; Chen G; Xu D; Ning Q; Zhao XP
    World J Gastroenterol; 2019 Apr; 25(16):1950-1963. PubMed ID: 31086463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased ILT2 expression contributes to dysfunction of CD56
    Zhang Y; Tong S; Li S; Wang X; Ren H; Yin W
    Antiviral Res; 2022 Sep; 205():105385. PubMed ID: 35917968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association among cytokine profiles of innate and adaptive immune responses and clinical-virological features in untreated patients with chronic hepatitis B.
    Gu Y; Lian Y; Zheng Q; Huang Z; Gu L; Bi Y; Li J; Huang Y; Wu Y; Chen L; Huang Y
    BMC Infect Dis; 2020 Jul; 20(1):509. PubMed ID: 32664850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD56
    Wang H; Zeng Y; Zhang M; Ma H; Xu B; Jiang H; Wang J; Li G
    Hum Immunol; 2019 Oct; 80(10):871-877. PubMed ID: 31326139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C.
    Bonorino P; Ramzan M; Camous X; Dufeu-Duchesne T; Thélu MA; Sturm N; Dariz A; Guillermet C; Pernollet M; Zarski JP; Marche PN; Leroy V; Jouvin-Marche E
    J Hepatol; 2009 Sep; 51(3):458-67. PubMed ID: 19596474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation and altered function of natural killer cells in hepatitis B virus patients treated with entecavir.
    Zhao PW; Jia FY; Shan YX; Ji HF; Feng JY; Niu JQ; Ayana DA; Jiang YF
    Clin Exp Pharmacol Physiol; 2013 Mar; 40(3):190-6. PubMed ID: 23278368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.